George Polimenakos

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation ("NHSF") of its flagship product, Tilray Purified Oral Solution (“OS”) CBD100, to be used in...

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers. “Tilray is transforming the industry globally...